Earnings Call · Q2 FY2021·2021-08-03

Q2 21EPS +5.41%·Rev n/aQ1 21EPS -100.00%*·Rev n/aQ4 20EPS 0.00%·Rev n/aQ3 20EPS +3.75%·Rev n/a⚠ consensus missing

RHYTHM PHARMACEUTICALS, INC. RYTM

David Connolly — Head of IR and Corporate Communications

David Meeker — Chair, President and Chief Executive Officer

Murray Stewart

Jennifer Chien

Yann Mazabraud

Hunter Smith — Chief Financial Officer

−4.5%1d on move date−5.3% vs SPY3d−19.5%5d−21.2%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RYTM calls or request research access.

More RYTM calls Browse calls Request research access